Selank and Semax: evaluating the Russian clinical peptides
Approved in one country, unstudied in most others — a framework for reading asymmetric evidence.
ScienceSelank
Also known as: TP-7
ClassSynthetic tuftsin analog
Research statusApproved in Russia; unapproved elsewhere
Independent tests0
Studies indexed1
Overview
Selank is a synthetic analog of the immune peptide tuftsin, developed and approved in Russia for anxiety-related indications as a nasal spray. Its mechanism is thought to involve GABAergic and monoamine modulation. Western trials are lacking.
Research & Studies
Studies library-
Selank anxiolytic activity in generalized anxiety disorder
Basis of Russian approval; methodology details unavailable in translated literature.
Latest Coverage
The Peptide Institute Weekly
Research. Testing. Regulation. No hype.
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
- New research, summarized in plain English
- Independent lab results as they publish
- Score and ranking movements